Primary Hyperoxaluria Type 1 (PH1)

American Society of Nephrology (ASN) 2026

Congress Details

October 21-25, 2026

Denver, CO, USA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Agenda

Coming soon

Presentation Type

Poster Presentation

Time

10:00 - 12:00 MST

Location

Exhibit Hall A Poster board: SA-PO0173

Title

Long-Term Lumasiran in a Subset of Patients Who Underwent Isolated Kidney Transplant: Data from ILLUMINATE-C

Presenter

Mini Michael
Texas Children's Hospital, Houston, Texas, United States

Coming soon

Presentation Type

Poster Presentation

Time

10:00 - 12:00 MST

Location

Exhibit Hall A Poster board: SA-PO0174

Title

Baseline Urinary Oxalate and Lumasiran Treatment Response in the ILLUMINATE-A Study

Presenter

David J. Sas
Mayo Clinic, Rochester, Minnesota, United States

Login and Sign up

Left Image

RNAiScience Data Hall is for healthcare professionals. By creating an account, you will have access to:

- All RNAi on-demand educational content
- Personalization experience with ability to bookmark content for future reference

First Name *

Last Name *

Enter your Institution Email *

Password *

Country *

Select Speciality *

Select Profession *

* Required Fields

By signing up you agree to Alnylam Terms of Conditions and Privacy Policy.